Total Voting Rights

RNS Number : 7181I

AstraZeneca PLC

01 September 2016

 

1 September 2016 14:30

Transparency Directive

Voting Rights and Capital

The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. On 31 August 2016 the issued share capital of AstraZeneca PLC with voting rights is 1,264,983,797 ordinary shares of US$0.25.  No shares are held in Treasury.  Therefore, the total number of voting rights in AstraZeneca PLC is 1,264,983,797.

The above figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, AstraZeneca PLC under the UK Financial Conduct Authority's Disclosure and Transparency Rules.

About AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology. The Company is also active in inflammation, infection and neuroscience through numerous collaborations. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com    

CONTACTS

Media Enquiries
Neil Burrows	UK/Global	[phone]
Vanessa Rhodes	UK/Global	[phone]
Karen Birmingham	UK/Global	[phone]
Rob Skelding	UK/Global	[phone]
Jacob Lund	Sweden	[phone]
Michele Meixell	US	[phone]
Investor Relations
UK
Thomas Kudsk Larsen		[phone]
Craig Marks	Finance, Fixed Income, M&A	[phone]
Nick Stone	Respiratory & Autoimmunity	[phone]
Henry Wheeler	Oncology	[phone]
Christer Gruvris	Infection & Neuroscience	[phone]
US
Lindsey Trickett	Cardiovascular & Metabolic Diseases	[phone]
Mitchell Chan	Oncology	[phone]
Toll-free		[phone]

Adrian Kemp

Company Secretary

AstraZeneca PLC

-ENDS-

 

END

 

 

TVRLLFFLAEILIIR